Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126022751 | 12602275 | 1 | I | 20160423 | 0 | 20160727 | 20160727 | DIR | 62.56 | YR | M | N | 80.80000 | KG | 20160722 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126022751 | 12602275 | 1 | PS | CASODEX | BICALUTAMIDE | 1 | 0 | 5800 | MG | ||||||||||
| 126022751 | 12602275 | 2 | SS | LEUPROLIDE ACETATE. | LEUPROLIDE ACETATE | 1 | 0 | 60 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126022751 | 12602275 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126022751 | 12602275 | Chills | |
| 126022751 | 12602275 | Headache | |
| 126022751 | 12602275 | Insomnia | |
| 126022751 | 12602275 | Pyrexia | |
| 126022751 | 12602275 | Sepsis | |
| 126022751 | 12602275 | Urinary retention | |
| 126022751 | 12602275 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126022751 | 12602275 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126022751 | 12602275 | 1 | 20160429 | 0 | ||
| 126022751 | 12602275 | 2 | 20160301 | 0 |